Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabozantinib vs Sunitinib in Advanced RCC (CABOSUN)
NCT01835158Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jul 2013
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cabozantinib in renal cell carcinoma (RCC), sponsored by National Cancer Institute. Started Jul 2013; status: completed.
02
Drugs
cabozantinib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT01835158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01835158.